Price to Operating Profit (P/OP)
since 2013
Paying user area
Try for free
IQVIA Holdings Inc. pages available for free this week:
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Reportable Segments
- Enterprise Value (EV)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2013
- Current Ratio since 2013
- Total Asset Turnover since 2013
- Price to Book Value (P/BV) since 2013
- Price to Sales (P/S) since 2013
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to IQVIA Holdings Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
IQVIA Holdings Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 11, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 13, 2014 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of IQVIA Holdings Inc. Annual Report.
- Share Price Trend
- The share price demonstrated a consistent upward trajectory from 2014 through 2022, increasing from $52.20 to a peak of $232.18. The greatest annual increases occurred between 2017 and 2018, and 2021 and 2022. However, a slight decline was observed in 2023, where the price decreased to $227.03 from $232.18 the previous year.
- Operating Profit Per Share (OPPS)
- The operating profit per share showed a generally positive growth trend over the period. Starting at $3.56 in 2014, OPPS rose steadily to $5.42 by 2016, before experiencing a notable dip to $2.72 in 2017. From 2017 onward, the metric increased continuously, peaking at $9.69 in 2023, indicating improved operational efficiency or profitability in recent years.
- Price to Operating Profit (P/OP) Ratio
- The P/OP ratio exhibited varied dynamics over the years. Initially, it decreased from 14.66 in 2014 to a low of 10.89 in 2016, suggestive of the stock becoming more attractively valued relative to its operating profits. From 2017, the ratio spiked sharply, reaching a high of 50.41 in 2021, implying elevated market expectations or price appreciation beyond operating profit growth. Subsequently, it declined to 23.44 by 2023, reflecting a partial normalization or correction in the valuation relative to operating profits.
- Overall Analysis
- The data reveals strong capital growth in the share price over the ten-year span, aligned with a general improvement in operating profit per share, despite some volatility in intermediate years. The fluctuations in the P/OP ratio suggest periods of changing market sentiment and valuation adjustments, with a peak around 2021 followed by a notable correction. The recent years indicate a phase of valuation realignment concurrent with significant gains in operating profitability.
Comparison to Competitors
IQVIA Holdings Inc., P/OP, long-term trends, comparison to competitors
| IQVIA Holdings Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | ||||||||
| Feb 16, 2022 | ||||||||
| Feb 12, 2021 | ||||||||
| Feb 18, 2020 | ||||||||
| Feb 19, 2019 | ||||||||
| Feb 16, 2018 | ||||||||
| Feb 16, 2017 | ||||||||
| Feb 11, 2016 | ||||||||
| Feb 12, 2015 | ||||||||
| Feb 13, 2014 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).